BioNTech to open mRNA vaccine plant in Singapore



BioNTech SE revealed on Monday it will open an mRNA vaccine facility in Singapore, which is intended to be “fully operational” by the end of 2023 and produce a range of mRNA-based products, …
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento